Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Christopher C. Parker
Based on 141 articles published since 2007
||||
Expertise Level
The expertise of Christopher C. Parker ranks in the
  • Top 0.042%
  • ... of 131,386 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 141 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Parker, C C   ·   Parker, Chris C   ·   Parker, Chris   ·   Parker, Christopher C   ·   Parker, Christopher
Work Locations
Details
Most likely:    Royal Marsden Hospital and Trust      
2017
  • Urology Research Group, Division of Surgery and Interventional Science, University College London, 132 Hampstead Road, NW1 2PS London, UK; Department of Urology, University College London Hospitals Trust, 235 Euston Road, NW1 2BU London, UK. Electronic address: · Department of Academic Urology, Royal Marsden Hospital, 203 Fulham Road, London SW3 6JJ, UK. · Urology Research Group, Division of Surgery and Interventional Science, University College London, 132 Hampstead Road, NW1 2PS London, UK; Department of Urology, University College London Hospitals Trust, 235 Euston Road, NW1 2BU London, UK. · Pubmed 28609648
  • Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. Electronic address: · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · University of Chicago Medical Center, Section of Urology, Chicago, IL, USA. · Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 28318726
  • Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Research Data Management and Statistics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom. · Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: · Pubmed 28939224
  • The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK. Electronic address: · Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ 07981, USA. · Yale University, New Haven, CT 06520, USA. · Comprehensive Cancer Center of Nevada, 3730 South Eastern Avenue, Las Vegas, NV 89169, USA. · Karolinska University Hospital, SE-171 76, Stockholm, Sweden. · Tulane Cancer Center, 150 South Liberty Street, New Orleans, LA 70112, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Weston Park Hospital, Sheffield, UK. · Pubmed 27930924
  • Health Economics Unit, University of Birmingham, Birmingham, UK. · Cancer Research UK Clinical Trials Unit (CRCTU Birmingham), University of Birmingham, Birmingham, UK. · Posthumously listed (previously CRCTU Birmingham), Birmingham, UK. · University Hospital Birmingham NHS Foundation Trust, Birmingham, UK. · Western General Hospital, Edinburgh, UK. · Belfast City Hospital, Belfast, UK. · Royal Marsden Hospital, London, UK. · Institute of Cancer and Genetics, Cardiff University, UK. · City Hospital, Birmingham, UK. · The Christie Hospital, Manchester, UK. · Kent Oncology Centre, Maidstone, Kent, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · St James' University Hospital, Leeds, UK. · Royal Derby Hospital, Derby, UK. · University of Liverpool, Liverpool, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Pubmed 27256016
  • 1 Cancer Research UK Cancer Imaging Centre, MRI Unit, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, UK. · 2 Academic Urology Unit, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · 3 Statistics Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 28609110
  • 1 Cancer Research UK Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 2 Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 3 Department of Histopathology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 28055249
2016
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26691314
  • Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Clinical Academic Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; Oncogenetics Team, Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Erasmus University Medical Center, Rotterdam, Netherlands. · Departments of Pathology Urology, Comprehensive Cancer Center and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Johns Hopkins Hospital, Baltimore, MA, USA. · Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 26074382
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Clatterbridge Cancer Centre, Wirral, UK. · The Institute of Cancer Research, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Brighton and Sussex University Hospitals, Brighton, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. · Christie Hospital, Manchester, UK. · Royal Surrey County Hospital, Guildford, UK. · Queen's University Belfast, Belfast, UK. · Lincoln County Hospital, Lincoln, UK. · Addenbrooke's Hospital, Cambridge, UK. · Ipswich Hospital, Ipswich, UK. · Cardiff University/Velindre Cancer Centre, Cardiff, UK. · University Hospital Coventry, Coventry, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27339115
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • University Hospital Birmingham NHS Foundation Trust, Birmingham, England. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, England. · Health Economics Unit, University of Birmingham, England. · Cancer Research UK Clinical Trials Unit, Birmingham, England. · Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland. · Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, Sutton, England. · Institute of Cancer and Genetics, Cardiff University, Cardiff, Wales. · Department of Oncology Pharmacy, Birmingham City Hospital, Birmingham, England. · Department of Clinical Oncology, The Christie Hospital, Manchester, England. · Department of Clinical Oncology, Kent Oncology Centre, Maidstone, England. · Rosemere Cancer Centre, Royal Preston Hospital, Lancashire, England. · Cancer Research UK Clinical Centre at Leeds, University of Leeds, St James' University Hospital, Leeds, England. · Department of Oncology, Royal Derby Hospital, Derby, England. · Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, England. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · Pubmed 26794729
  • Institute of Human Genetics, University of Ulm, Ulm, Germany. · Department of Urology, University of Ulm, Ulm, Germany. · Fred Hutchinson Cancer Research Center, Division of Public Health Science, Seattle, Washington, USA. · Cancer, Genetics and Immunology, Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Biomedical Technology/BioMediTech, University of Tampere, Tampere, Finland. · Department of Medical Biochemistry and Genetics, University of Turku, and Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · The Institute of Cancer Research, London, UK. · Royal Marsden National Health Service Foundation Trust, London and Sutton, UK. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · National Human Genome Research Institute, NIH, Bethesda, MD, USA. · Department of Urology, Vivantes Humboldt Hospital, Berlin, Germany. · Department of Urology, University Hospital Charité, Berlin, Germany. · Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Urology, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Department of Biological Science, University of East Anglia, Norwich, UK. · Department of Pathology, Portuguese Oncology Institute, Porto, Portugal. · Department of Urology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. · Institute of Pathology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. · Institute of Pathology, University Bern, Bern Switzerland. · Department of Urology, Klinik am Eichert, Göppingen, Germany. · Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Pathology of the University Medical Center Schleswig-Holstein, Campus Luebeck and the Research Center Borstel, Leibniz Center for Medicine and Biosciences, Luebeck and Borstel, Germany. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA. · University of Utah/ARUP Laboratories, Salt Lake City, UT, USA. · Centre for Cancer Genetics Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA. · Pubmed 27798103
  • Royal Marsden Hospital, Sutton, London, UK. Electronic address: · Cancer Treatment Centers of America, Tulsa, OK, USA. · Washington University School of Medicine, St Louis, MO, USA. · Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Norwegian Radium Hospital, Oslo, Norway. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Sheffield, Sheffield, South Yorkshire, UK. · Karolinska University Hospital, Stockholm, Sweden. · Tulane Cancer Center, New Orleans, LA, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · St. James University Hospital, Leeds, Yorkshire, UK. · Pubmed 27344296
  • School of Social and Community Medicine, University of Bristol, Bristol, UK. · NIHR Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK. · Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. · Institution of Surgical Sciences, Department of Urology, Uppsala University, Uppsala, Sweden. · Department of Urology, Johns Hopkins School of Medicine, Baltimore, MA, USA. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · National Institute on Aging, National Institutes of Health, Baltimore, MA, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Faculty of Life Sciences and Medicine, King's College London, London, UK. · Regional Cancer Centre, Uppsala/Örebro Region, Uppsala, Sweden. · Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. · Department of Oncology, University of Cambridge, Cambridge, UK. · Academic Urology Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK. · Pubmed 26799945
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26482887
2015
  • The Institute of Cancer Research, London, UK. · Clatterbridge Cancer Centre, Wirral, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · Brighton and Sussex University Hospitals, Brighton, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Christie Hospital, Manchester, UK. · Ipswich Hospital, Ipswich, UK. · Addenbrooke's Hospital, Cambridge, UK. · Rosemere Cancer Centre, Royal Preston Hospital, UK. · Cardiff University, Cardiff, UK; Velindre Cancer Centre, Cardiff, UK. · Whiston Hospital, Prescot, UK. · Lincoln County Hospital, Lincoln, UK. · Southport General Infirmary, Southport, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. · Queen's University Belfast, Belfast, UK. · The Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26522334
  • Joint Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, United Kingdom · Department of Radiation Physics, Radionuklidcentralen, Skåne University Hospital Lund, Lund, Sweden. · Department of Urology, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; and. · Department of Nuclear Medicine, Guy's Hospital, London, United Kingdom. · Joint Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 26182965
  • Royal Marsden Hospital, Sutton, United Kingdom. · Pubmed 27058695
  • CRUK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 26258905
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 25454616
  • University of Warwick, Coventry, UK. Electronic address: · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Queen Alexandra Hospital, Portsmouth, UK. · Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Hospital, Northwood, Middlesex, UK. · University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Royal Surrey County Hospital, Guildford, UK. · Velindre Hospital, Cardiff, UK. · Western General Hospital, Edinburgh, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Kantonsspital Graübunden, Chur, Switzerland. · Department of Urology, University Hospital, Bern, Switzerland. · Pubmed 25301760
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Division of Urologic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, MO, USA. · Office of the Chief Medical Officer, American Cancer Society, Atlanta, GA, USA; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA. · Department of Clinical Cancer Prevention, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Molecular Pathology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria. · Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Urology, University of Oxford, Oxford, UK. · Medical School, King's College London, London, UK; Regional Cancer Center Uppsala Orebro and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Surgery (Urology), Laboratory Medicine, and Medicine (GU-Oncology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Lund University, University Hospital UMAS, Malmö, Sweden. · Department of Urology, Vienna University Medical School, Vienna, Austria. · Biological Chemistry, Public Health, and Epidemiology, School of Medicine, University of California, Irvine, CA, USA. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Prostate and Urologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany. · Director of Assay Development, IR2Dx Inc Moraga, CA, USA. · Urology, Radboud University Medical Center, Nijmegen, Netherlands. · Department of Urology, Kantonsspital St Gallen, St Gallen, Switzerland. · Urologie, Schön Klinik Nürnberg/Fürth & Urologie 24, Fürth, Germany. · Erasmus University and Erasmus Medical Centre, Rotterdam, Netherlands. · Department of Urology, University Hospital Tübingen, Tuebingen, Germany. · Department of Urology, Université Catholique de Louvain, Brussels, Belgium. · Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Health Care System, and Section of General Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 25281467
  • Division of Surgery, University College London, UK. · Oslo University Hospital, Oslo, Norway. · St James's Institute of Oncology, Leeds, UK. · Newcastle University and Freeman Hospital, Newcastle, UK. · MRC Clinical Trials Unit, London, UK. · University of Oxford, Oxford, UK. · Royal Marsden Hospital, London, UK. · University of Sheffield, Sheffield, UK. · National Cancer Research Institute, London, UK. · University of Hull, Hull, UK. · London School of Hygiene and Tropical Medicine, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, USA. · University of Minnesota School of Medicine, Minnesota, USA. · Pubmed 24751803
  • Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: · Tulane Cancer Center, New Orleans, LA, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Ullevål University Hospital, Oslo, Norway. · Haukeland University Hospital, Bergen, Norway. · Christie Hospital, Manchester, UK. · St James's University Hospital, Leeds, UK. · Karolinska University Hospital, Stockholm, Sweden. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · Algeta ASA (Bayer), Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 25439694
  • Tulane Cancer Center, New Orleans, LA, USA. Electronic address: · Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden. · Akershus University Hospital, Department of Oncology, Lørenskog, Norway. · Haukeland University Hospital, Bergen, Norway. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Oslo University Hospital, Radiumhospital, Oslo, Norway. · Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic. · Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland. · Christie Hospital, Manchester, UK. · Umeå University, Department of Radiation Sciences, Oncology, Sweden. · Ullevål University Hospital, Oslo, Norway. · Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK. · Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK. · St Olavs Hospital, Trondheim, Norway. · Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Algeta ASA, Kjelsaas, Oslo, Norway. · Bayer Healthcare, Whippany, NJ, USA. · Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 24836273
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2013
2012
  • Royal Marsden National Health Service Foundation Trust, Academic Urology Unit, Sutton SM2 5PT, UK. · Pubmed 22277569
2011
2009
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 19549256
2007
  • Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research and the Royal, Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 17428247
  • Academic Urology Unit, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17535273
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2014
  • MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. · Pubmed 24103544
  • From the San Camillo Forlanini Hospital, Rome, Italy; Yale University Cancer Center, New Haven, CT; Center for Cancer Research, National Cancer Institute, Bethesda, MD; The Royal Marsden Hospital, London, United Kingdom. · Pubmed 24857068
2013
  • The Royal Marsden Hospital, Sutton, Surrey, UK; The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 23473579
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
2011
  • Department of Nuclear Medicine and PET, Royal Marsden Hospital, Downs Rd, Sutton, Surrey, SM2 5PT, UK. · Pubmed 20697891
  • Cancer Research UK Clinical MR Research Group, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 21343500
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. · Pubmed 20714343
  • Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20216316
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20456339
2009
  • Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 19470933
  • Academic Uro-oncology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK. · Pubmed 19624290
  • Academic Unit of Radiotherapy and Oncology, Department of Radiology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19095345
  • Academic Uro-oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18993040
2008
  • Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 18645193
  • Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, United Kingdom. · Pubmed 18829513
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom. · Pubmed 18342430
  • Department of Radiotherapy, Royal Marsden NHS Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 17996391
  • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17941935
  • Academic Unit of Radiotherapy & Oncology, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17850368
2007
  • Drug Development Unit and Department of Academic Urology, Royal Marsden Hospital, Centre for Cancer Therapeutics, Institute for Cancer Research, Surrey, United Kingdom. · Pubmed 17235043
  • Academic Urology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK. · Pubmed 18036691
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom. · Pubmed 17631355
  • Psychological Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 17550414
  • Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17537213
  • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17499490
Probable:    University of London      
2017
  • Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. Electronic address: · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · University of Chicago Medical Center, Section of Urology, Chicago, IL, USA. · Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 28318726
  • Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Research Data Management and Statistics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom. · Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: · Pubmed 28939224
  • 1 Cancer Research UK Cancer Imaging Centre, MRI Unit, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, UK. · 2 Academic Urology Unit, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · 3 Statistics Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 28609110
  • The Royal Marsden NHS Foundation Trust, London, United Kingdom. · The Institute of Cancer Research, London, United Kingdom; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain. · The Institute of Cancer Research, London, United Kingdom. · The Institute of Cancer Research, London, United Kingdom. Electronic address: · Pubmed 28571827
  • 1 Cancer Research UK Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 2 Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 3 Department of Histopathology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 28055249
2016
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26691314
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Clatterbridge Cancer Centre, Wirral, UK. · The Institute of Cancer Research, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Brighton and Sussex University Hospitals, Brighton, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. · Christie Hospital, Manchester, UK. · Royal Surrey County Hospital, Guildford, UK. · Queen's University Belfast, Belfast, UK. · Lincoln County Hospital, Lincoln, UK. · Addenbrooke's Hospital, Cambridge, UK. · Ipswich Hospital, Ipswich, UK. · Cardiff University/Velindre Cancer Centre, Cardiff, UK. · University Hospital Coventry, Coventry, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27339115
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • University Hospital Birmingham NHS Foundation Trust, Birmingham, England. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, England. · Health Economics Unit, University of Birmingham, England. · Cancer Research UK Clinical Trials Unit, Birmingham, England. · Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland. · Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, Sutton, England. · Institute of Cancer and Genetics, Cardiff University, Cardiff, Wales. · Department of Oncology Pharmacy, Birmingham City Hospital, Birmingham, England. · Department of Clinical Oncology, The Christie Hospital, Manchester, England. · Department of Clinical Oncology, Kent Oncology Centre, Maidstone, England. · Rosemere Cancer Centre, Royal Preston Hospital, Lancashire, England. · Cancer Research UK Clinical Centre at Leeds, University of Leeds, St James' University Hospital, Leeds, England. · Department of Oncology, Royal Derby Hospital, Derby, England. · Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, England. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · Pubmed 26794729
  • School of Social and Community Medicine, University of Bristol, Bristol, UK. · NIHR Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK. · Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. · Institution of Surgical Sciences, Department of Urology, Uppsala University, Uppsala, Sweden. · Department of Urology, Johns Hopkins School of Medicine, Baltimore, MA, USA. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · National Institute on Aging, National Institutes of Health, Baltimore, MA, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Faculty of Life Sciences and Medicine, King's College London, London, UK. · Regional Cancer Centre, Uppsala/Örebro Region, Uppsala, Sweden. · Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. · Department of Oncology, University of Cambridge, Cambridge, UK. · Academic Urology Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK. · Pubmed 26799945
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26482887
2015
  • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York. · Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana. · Department of Clinical Oncology, Institute of Cancer Research, Sutton, United Kingdom. · Department of Oncology, Norwegian Radium Hospital and Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio. Electronic address: · Pubmed 25832684
  • CRUK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 26258905
  • University of Warwick, Coventry, UK. Electronic address: · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Queen Alexandra Hospital, Portsmouth, UK. · Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Hospital, Northwood, Middlesex, UK. · University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Royal Surrey County Hospital, Guildford, UK. · Velindre Hospital, Cardiff, UK. · Western General Hospital, Edinburgh, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Kantonsspital Graübunden, Chur, Switzerland. · Department of Urology, University Hospital, Bern, Switzerland. · Pubmed 25301760
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: · Tulane Cancer Center, New Orleans, LA, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Ullevål University Hospital, Oslo, Norway. · Haukeland University Hospital, Bergen, Norway. · Christie Hospital, Manchester, UK. · St James's University Hospital, Leeds, UK. · Karolinska University Hospital, Stockholm, Sweden. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · Algeta ASA (Bayer), Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 25439694
  • Tulane Cancer Center, New Orleans, LA, USA. Electronic address: · Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden. · Akershus University Hospital, Department of Oncology, Lørenskog, Norway. · Haukeland University Hospital, Bergen, Norway. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Oslo University Hospital, Radiumhospital, Oslo, Norway. · Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic. · Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland. · Christie Hospital, Manchester, UK. · Umeå University, Department of Radiation Sciences, Oncology, Sweden. · Ullevål University Hospital, Oslo, Norway. · Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK. · Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK. · St Olavs Hospital, Trondheim, Norway. · Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Algeta ASA, Kjelsaas, Oslo, Norway. · Bayer Healthcare, Whippany, NJ, USA. · Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 24836273
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2011
2009
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 19549256
2007
  • Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research and the Royal, Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 17428247
  • Academic Urology Unit, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17535273
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2014
  • MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. · Pubmed 24103544
2013
  • The Institute of Cancer Research, Sutton, UK. · Pubmed 23535732
  • The Royal Marsden Hospital, Sutton, Surrey, UK; The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 23473579
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
2011
  • The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 21743467
  • Cancer Research UK Clinical MR Research Group, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 21343500
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. · Pubmed 20714343
  • Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20216316
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20456339
2009
  • Section of Cancer Genetics, The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19050691
  • The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19767753
  • The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 19339269
  • Academic Unit of Radiotherapy and Oncology, Department of Radiology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19095345
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK. · Pubmed 19091392
  • Academic Uro-oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18993040
2008
  • Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK. · Pubmed 18568350
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18949747
  • Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, United Kingdom. · Pubmed 18829513
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom. · Pubmed 18342430
  • The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK. · Pubmed 18264097
  • Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK. · Pubmed 18253858
  • Department of Radiotherapy, Royal Marsden NHS Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 17996391
  • Academic Unit of Radiotherapy & Oncology, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17850368
2007
  • Drug Development Unit and Department of Academic Urology, Royal Marsden Hospital, Centre for Cancer Therapeutics, Institute for Cancer Research, Surrey, United Kingdom. · Pubmed 17235043
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom. · Pubmed 17631355
  • Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17537213
Probable:    University College London      
2017
  • Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. Electronic address: · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · University of Chicago Medical Center, Section of Urology, Chicago, IL, USA. · Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 28318726
  • Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Research Data Management and Statistics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom. · Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: · Pubmed 28939224
  • 1 Cancer Research UK Cancer Imaging Centre, MRI Unit, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, UK. · 2 Academic Urology Unit, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · 3 Statistics Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 28609110
  • 1 Cancer Research UK Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 2 Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 3 Department of Histopathology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 28055249
2016
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26691314
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • School of Social and Community Medicine, University of Bristol, Bristol, UK. · NIHR Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK. · Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. · Institution of Surgical Sciences, Department of Urology, Uppsala University, Uppsala, Sweden. · Department of Urology, Johns Hopkins School of Medicine, Baltimore, MA, USA. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · National Institute on Aging, National Institutes of Health, Baltimore, MA, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Faculty of Life Sciences and Medicine, King's College London, London, UK. · Regional Cancer Centre, Uppsala/Örebro Region, Uppsala, Sweden. · Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. · Department of Oncology, University of Cambridge, Cambridge, UK. · Academic Urology Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK. · Pubmed 26799945
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26482887
2015
  • CRUK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 26258905
2014
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2009
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 19549256
2007
  • Academic Urology Unit, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17535273
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2014
  • MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. · Pubmed 24103544
2012
  • Division of Surgery and Interventional Sciences, University College London, London, UK. · Pubmed 22077593
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. · Pubmed 20714343
2008
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom. · Pubmed 18342430
2007
  • Drug Development Unit and Department of Academic Urology, Royal Marsden Hospital, Centre for Cancer Therapeutics, Institute for Cancer Research, Surrey, United Kingdom. · Pubmed 17235043
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 141 total) written by Christopher C. Parker about Prostatic Neoplasms:

  • When no treatment is the best treatment: Active surveillance strategies for low risk prostate cancers. 2017
  • Low-risk Prostate Cancer: Identification, Management, and Outcomes. 2017
  • Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer. 2017
  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. 2017
  • Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial. 2017
  • Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial. 2017
  • Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). 2017
  • Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth? 2017
  • Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital. 2017
  • Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Christopher C. Parker using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Royal Marsden Hospital and Trust
University of London
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Royal Marsden Hospital and Trust
2017
  • Urology Research Group, Division of Surgery and Interventional Science, University College London, 132 Hampstead Road, NW1 2PS London, UK; Department of Urology, University College London Hospitals Trust, 235 Euston Road, NW1 2BU London, UK. Electronic address: · Department of Academic Urology, Royal Marsden Hospital, 203 Fulham Road, London SW3 6JJ, UK. · Urology Research Group, Division of Surgery and Interventional Science, University College London, 132 Hampstead Road, NW1 2PS London, UK; Department of Urology, University College London Hospitals Trust, 235 Euston Road, NW1 2BU London, UK. · Pubmed 28609648
  • Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. Electronic address: · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · University of Chicago Medical Center, Section of Urology, Chicago, IL, USA. · Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 28318726
  • Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Research Data Management and Statistics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom. · Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: · Pubmed 28939224
  • The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK. Electronic address: · Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ 07981, USA. · Yale University, New Haven, CT 06520, USA. · Comprehensive Cancer Center of Nevada, 3730 South Eastern Avenue, Las Vegas, NV 89169, USA. · Karolinska University Hospital, SE-171 76, Stockholm, Sweden. · Tulane Cancer Center, 150 South Liberty Street, New Orleans, LA 70112, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Weston Park Hospital, Sheffield, UK. · Pubmed 27930924
  • Health Economics Unit, University of Birmingham, Birmingham, UK. · Cancer Research UK Clinical Trials Unit (CRCTU Birmingham), University of Birmingham, Birmingham, UK. · Posthumously listed (previously CRCTU Birmingham), Birmingham, UK. · University Hospital Birmingham NHS Foundation Trust, Birmingham, UK. · Western General Hospital, Edinburgh, UK. · Belfast City Hospital, Belfast, UK. · Royal Marsden Hospital, London, UK. · Institute of Cancer and Genetics, Cardiff University, UK. · City Hospital, Birmingham, UK. · The Christie Hospital, Manchester, UK. · Kent Oncology Centre, Maidstone, Kent, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · St James' University Hospital, Leeds, UK. · Royal Derby Hospital, Derby, UK. · University of Liverpool, Liverpool, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Pubmed 27256016
  • 1 Cancer Research UK Cancer Imaging Centre, MRI Unit, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, UK. · 2 Academic Urology Unit, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · 3 Statistics Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 28609110
  • 1 Cancer Research UK Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 2 Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 3 Department of Histopathology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 28055249
2016
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26691314
  • Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Clinical Academic Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; Oncogenetics Team, Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Erasmus University Medical Center, Rotterdam, Netherlands. · Departments of Pathology Urology, Comprehensive Cancer Center and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Johns Hopkins Hospital, Baltimore, MA, USA. · Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 26074382
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Clatterbridge Cancer Centre, Wirral, UK. · The Institute of Cancer Research, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Brighton and Sussex University Hospitals, Brighton, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. · Christie Hospital, Manchester, UK. · Royal Surrey County Hospital, Guildford, UK. · Queen's University Belfast, Belfast, UK. · Lincoln County Hospital, Lincoln, UK. · Addenbrooke's Hospital, Cambridge, UK. · Ipswich Hospital, Ipswich, UK. · Cardiff University/Velindre Cancer Centre, Cardiff, UK. · University Hospital Coventry, Coventry, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27339115
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • University Hospital Birmingham NHS Foundation Trust, Birmingham, England. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, England. · Health Economics Unit, University of Birmingham, England. · Cancer Research UK Clinical Trials Unit, Birmingham, England. · Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland. · Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, Sutton, England. · Institute of Cancer and Genetics, Cardiff University, Cardiff, Wales. · Department of Oncology Pharmacy, Birmingham City Hospital, Birmingham, England. · Department of Clinical Oncology, The Christie Hospital, Manchester, England. · Department of Clinical Oncology, Kent Oncology Centre, Maidstone, England. · Rosemere Cancer Centre, Royal Preston Hospital, Lancashire, England. · Cancer Research UK Clinical Centre at Leeds, University of Leeds, St James' University Hospital, Leeds, England. · Department of Oncology, Royal Derby Hospital, Derby, England. · Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, England. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · Pubmed 26794729
  • Institute of Human Genetics, University of Ulm, Ulm, Germany. · Department of Urology, University of Ulm, Ulm, Germany. · Fred Hutchinson Cancer Research Center, Division of Public Health Science, Seattle, Washington, USA. · Cancer, Genetics and Immunology, Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Biomedical Technology/BioMediTech, University of Tampere, Tampere, Finland. · Department of Medical Biochemistry and Genetics, University of Turku, and Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · The Institute of Cancer Research, London, UK. · Royal Marsden National Health Service Foundation Trust, London and Sutton, UK. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · National Human Genome Research Institute, NIH, Bethesda, MD, USA. · Department of Urology, Vivantes Humboldt Hospital, Berlin, Germany. · Department of Urology, University Hospital Charité, Berlin, Germany. · Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Urology, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Department of Biological Science, University of East Anglia, Norwich, UK. · Department of Pathology, Portuguese Oncology Institute, Porto, Portugal. · Department of Urology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. · Institute of Pathology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. · Institute of Pathology, University Bern, Bern Switzerland. · Department of Urology, Klinik am Eichert, Göppingen, Germany. · Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Pathology of the University Medical Center Schleswig-Holstein, Campus Luebeck and the Research Center Borstel, Leibniz Center for Medicine and Biosciences, Luebeck and Borstel, Germany. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA. · University of Utah/ARUP Laboratories, Salt Lake City, UT, USA. · Centre for Cancer Genetics Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA. · Pubmed 27798103
  • Royal Marsden Hospital, Sutton, London, UK. Electronic address: · Cancer Treatment Centers of America, Tulsa, OK, USA. · Washington University School of Medicine, St Louis, MO, USA. · Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Norwegian Radium Hospital, Oslo, Norway. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Sheffield, Sheffield, South Yorkshire, UK. · Karolinska University Hospital, Stockholm, Sweden. · Tulane Cancer Center, New Orleans, LA, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · St. James University Hospital, Leeds, Yorkshire, UK. · Pubmed 27344296
  • School of Social and Community Medicine, University of Bristol, Bristol, UK. · NIHR Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK. · Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. · Institution of Surgical Sciences, Department of Urology, Uppsala University, Uppsala, Sweden. · Department of Urology, Johns Hopkins School of Medicine, Baltimore, MA, USA. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · National Institute on Aging, National Institutes of Health, Baltimore, MA, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Faculty of Life Sciences and Medicine, King's College London, London, UK. · Regional Cancer Centre, Uppsala/Örebro Region, Uppsala, Sweden. · Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. · Department of Oncology, University of Cambridge, Cambridge, UK. · Academic Urology Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK. · Pubmed 26799945
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26482887
2015
  • The Institute of Cancer Research, London, UK. · Clatterbridge Cancer Centre, Wirral, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · Brighton and Sussex University Hospitals, Brighton, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Christie Hospital, Manchester, UK. · Ipswich Hospital, Ipswich, UK. · Addenbrooke's Hospital, Cambridge, UK. · Rosemere Cancer Centre, Royal Preston Hospital, UK. · Cardiff University, Cardiff, UK; Velindre Cancer Centre, Cardiff, UK. · Whiston Hospital, Prescot, UK. · Lincoln County Hospital, Lincoln, UK. · Southport General Infirmary, Southport, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. · Queen's University Belfast, Belfast, UK. · The Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26522334
  • Joint Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, United Kingdom · Department of Radiation Physics, Radionuklidcentralen, Skåne University Hospital Lund, Lund, Sweden. · Department of Urology, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; and. · Department of Nuclear Medicine, Guy's Hospital, London, United Kingdom. · Joint Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 26182965
  • Royal Marsden Hospital, Sutton, United Kingdom. · Pubmed 27058695
  • CRUK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 26258905
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 25454616
  • University of Warwick, Coventry, UK. Electronic address: · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Queen Alexandra Hospital, Portsmouth, UK. · Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Hospital, Northwood, Middlesex, UK. · University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Royal Surrey County Hospital, Guildford, UK. · Velindre Hospital, Cardiff, UK. · Western General Hospital, Edinburgh, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Kantonsspital Graübunden, Chur, Switzerland. · Department of Urology, University Hospital, Bern, Switzerland. · Pubmed 25301760
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Division of Urologic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, MO, USA. · Office of the Chief Medical Officer, American Cancer Society, Atlanta, GA, USA; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA. · Department of Clinical Cancer Prevention, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Molecular Pathology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria. · Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Urology, University of Oxford, Oxford, UK. · Medical School, King's College London, London, UK; Regional Cancer Center Uppsala Orebro and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Surgery (Urology), Laboratory Medicine, and Medicine (GU-Oncology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Lund University, University Hospital UMAS, Malmö, Sweden. · Department of Urology, Vienna University Medical School, Vienna, Austria. · Biological Chemistry, Public Health, and Epidemiology, School of Medicine, University of California, Irvine, CA, USA. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Prostate and Urologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany. · Director of Assay Development, IR2Dx Inc Moraga, CA, USA. · Urology, Radboud University Medical Center, Nijmegen, Netherlands. · Department of Urology, Kantonsspital St Gallen, St Gallen, Switzerland. · Urologie, Schön Klinik Nürnberg/Fürth & Urologie 24, Fürth, Germany. · Erasmus University and Erasmus Medical Centre, Rotterdam, Netherlands. · Department of Urology, University Hospital Tübingen, Tuebingen, Germany. · Department of Urology, Université Catholique de Louvain, Brussels, Belgium. · Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Health Care System, and Section of General Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Pubmed 25281467
  • Division of Surgery, University College London, UK. · Oslo University Hospital, Oslo, Norway. · St James's Institute of Oncology, Leeds, UK. · Newcastle University and Freeman Hospital, Newcastle, UK. · MRC Clinical Trials Unit, London, UK. · University of Oxford, Oxford, UK. · Royal Marsden Hospital, London, UK. · University of Sheffield, Sheffield, UK. · National Cancer Research Institute, London, UK. · University of Hull, Hull, UK. · London School of Hygiene and Tropical Medicine, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, USA. · University of Minnesota School of Medicine, Minnesota, USA. · Pubmed 24751803
  • Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: · Tulane Cancer Center, New Orleans, LA, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Ullevål University Hospital, Oslo, Norway. · Haukeland University Hospital, Bergen, Norway. · Christie Hospital, Manchester, UK. · St James's University Hospital, Leeds, UK. · Karolinska University Hospital, Stockholm, Sweden. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · Algeta ASA (Bayer), Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 25439694
  • Tulane Cancer Center, New Orleans, LA, USA. Electronic address: · Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden. · Akershus University Hospital, Department of Oncology, Lørenskog, Norway. · Haukeland University Hospital, Bergen, Norway. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Oslo University Hospital, Radiumhospital, Oslo, Norway. · Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic. · Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland. · Christie Hospital, Manchester, UK. · Umeå University, Department of Radiation Sciences, Oncology, Sweden. · Ullevål University Hospital, Oslo, Norway. · Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK. · Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK. · St Olavs Hospital, Trondheim, Norway. · Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Algeta ASA, Kjelsaas, Oslo, Norway. · Bayer Healthcare, Whippany, NJ, USA. · Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 24836273
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2013
2012
  • Royal Marsden National Health Service Foundation Trust, Academic Urology Unit, Sutton SM2 5PT, UK. · Pubmed 22277569
2011
2009
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 19549256
2007
  • Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research and the Royal, Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 17428247
  • Academic Urology Unit, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17535273
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2014
  • MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. · Pubmed 24103544
  • From the San Camillo Forlanini Hospital, Rome, Italy; Yale University Cancer Center, New Haven, CT; Center for Cancer Research, National Cancer Institute, Bethesda, MD; The Royal Marsden Hospital, London, United Kingdom. · Pubmed 24857068
2013
  • The Royal Marsden Hospital, Sutton, Surrey, UK; The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 23473579
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
2011
  • Department of Nuclear Medicine and PET, Royal Marsden Hospital, Downs Rd, Sutton, Surrey, SM2 5PT, UK. · Pubmed 20697891
  • Cancer Research UK Clinical MR Research Group, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 21343500
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. · Pubmed 20714343
  • Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20216316
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20456339
2009
  • Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 19470933
  • Academic Uro-oncology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK. · Pubmed 19624290
  • Academic Unit of Radiotherapy and Oncology, Department of Radiology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19095345
  • Academic Uro-oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18993040
2008
  • Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 18645193
  • Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, United Kingdom. · Pubmed 18829513
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom. · Pubmed 18342430
  • Department of Radiotherapy, Royal Marsden NHS Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 17996391
  • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17941935
  • Academic Unit of Radiotherapy & Oncology, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17850368
2007
  • Drug Development Unit and Department of Academic Urology, Royal Marsden Hospital, Centre for Cancer Therapeutics, Institute for Cancer Research, Surrey, United Kingdom. · Pubmed 17235043
  • Academic Urology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK. · Pubmed 18036691
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom. · Pubmed 17631355
  • Psychological Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 17550414
  • Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17537213
  • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17499490
University of London
2017
  • Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. Electronic address: · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · University of Chicago Medical Center, Section of Urology, Chicago, IL, USA. · Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 28318726
  • Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Research Data Management and Statistics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom. · Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: · Pubmed 28939224
  • 1 Cancer Research UK Cancer Imaging Centre, MRI Unit, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, UK. · 2 Academic Urology Unit, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · 3 Statistics Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 28609110
  • The Royal Marsden NHS Foundation Trust, London, United Kingdom. · The Institute of Cancer Research, London, United Kingdom; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain. · The Institute of Cancer Research, London, United Kingdom. · The Institute of Cancer Research, London, United Kingdom. Electronic address: · Pubmed 28571827
  • 1 Cancer Research UK Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 2 Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 3 Department of Histopathology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 28055249
2016
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26691314
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Clatterbridge Cancer Centre, Wirral, UK. · The Institute of Cancer Research, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Brighton and Sussex University Hospitals, Brighton, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. · Christie Hospital, Manchester, UK. · Royal Surrey County Hospital, Guildford, UK. · Queen's University Belfast, Belfast, UK. · Lincoln County Hospital, Lincoln, UK. · Addenbrooke's Hospital, Cambridge, UK. · Ipswich Hospital, Ipswich, UK. · Cardiff University/Velindre Cancer Centre, Cardiff, UK. · University Hospital Coventry, Coventry, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27339115
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • University Hospital Birmingham NHS Foundation Trust, Birmingham, England. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, England. · Health Economics Unit, University of Birmingham, England. · Cancer Research UK Clinical Trials Unit, Birmingham, England. · Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland. · Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, Sutton, England. · Institute of Cancer and Genetics, Cardiff University, Cardiff, Wales. · Department of Oncology Pharmacy, Birmingham City Hospital, Birmingham, England. · Department of Clinical Oncology, The Christie Hospital, Manchester, England. · Department of Clinical Oncology, Kent Oncology Centre, Maidstone, England. · Rosemere Cancer Centre, Royal Preston Hospital, Lancashire, England. · Cancer Research UK Clinical Centre at Leeds, University of Leeds, St James' University Hospital, Leeds, England. · Department of Oncology, Royal Derby Hospital, Derby, England. · Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, England. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · Pubmed 26794729
  • School of Social and Community Medicine, University of Bristol, Bristol, UK. · NIHR Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK. · Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. · Institution of Surgical Sciences, Department of Urology, Uppsala University, Uppsala, Sweden. · Department of Urology, Johns Hopkins School of Medicine, Baltimore, MA, USA. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · National Institute on Aging, National Institutes of Health, Baltimore, MA, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Faculty of Life Sciences and Medicine, King's College London, London, UK. · Regional Cancer Centre, Uppsala/Örebro Region, Uppsala, Sweden. · Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. · Department of Oncology, University of Cambridge, Cambridge, UK. · Academic Urology Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK. · Pubmed 26799945
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26482887
2015
  • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York. · Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana. · Department of Clinical Oncology, Institute of Cancer Research, Sutton, United Kingdom. · Department of Oncology, Norwegian Radium Hospital and Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio. Electronic address: · Pubmed 25832684
  • CRUK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 26258905
  • University of Warwick, Coventry, UK. Electronic address: · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Queen Alexandra Hospital, Portsmouth, UK. · Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Hospital, Northwood, Middlesex, UK. · University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Royal Surrey County Hospital, Guildford, UK. · Velindre Hospital, Cardiff, UK. · Western General Hospital, Edinburgh, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Kantonsspital Graübunden, Chur, Switzerland. · Department of Urology, University Hospital, Bern, Switzerland. · Pubmed 25301760
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: · Tulane Cancer Center, New Orleans, LA, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Ullevål University Hospital, Oslo, Norway. · Haukeland University Hospital, Bergen, Norway. · Christie Hospital, Manchester, UK. · St James's University Hospital, Leeds, UK. · Karolinska University Hospital, Stockholm, Sweden. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · Algeta ASA (Bayer), Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 25439694
  • Tulane Cancer Center, New Orleans, LA, USA. Electronic address: · Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden. · Akershus University Hospital, Department of Oncology, Lørenskog, Norway. · Haukeland University Hospital, Bergen, Norway. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Oslo University Hospital, Radiumhospital, Oslo, Norway. · Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic. · Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland. · Christie Hospital, Manchester, UK. · Umeå University, Department of Radiation Sciences, Oncology, Sweden. · Ullevål University Hospital, Oslo, Norway. · Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK. · Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK. · St Olavs Hospital, Trondheim, Norway. · Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Algeta ASA, Kjelsaas, Oslo, Norway. · Bayer Healthcare, Whippany, NJ, USA. · Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 24836273
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2011
2009
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 19549256
2007
  • Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research and the Royal, Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 17428247
  • Academic Urology Unit, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17535273
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2014
  • MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. · Pubmed 24103544
2013
  • The Institute of Cancer Research, Sutton, UK. · Pubmed 23535732
  • The Royal Marsden Hospital, Sutton, Surrey, UK; The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 23473579
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
2011
  • The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 21743467
  • Cancer Research UK Clinical MR Research Group, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 21343500
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. · Pubmed 20714343
  • Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20216316
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20456339
2009
  • Section of Cancer Genetics, The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19050691
  • The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19767753
  • The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 19339269
  • Academic Unit of Radiotherapy and Oncology, Department of Radiology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19095345
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK. · Pubmed 19091392
  • Academic Uro-oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18993040
2008
  • Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK. · Pubmed 18568350
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18949747
  • Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, United Kingdom. · Pubmed 18829513
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom. · Pubmed 18342430
  • The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK. · Pubmed 18264097
  • Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK. · Pubmed 18253858
  • Department of Radiotherapy, Royal Marsden NHS Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 17996391
  • Academic Unit of Radiotherapy & Oncology, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17850368
2007
  • Drug Development Unit and Department of Academic Urology, Royal Marsden Hospital, Centre for Cancer Therapeutics, Institute for Cancer Research, Surrey, United Kingdom. · Pubmed 17235043
  • Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom. · Pubmed 17631355
  • Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 17537213
University College London
2017
  • Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. Electronic address: · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · University of Chicago Medical Center, Section of Urology, Chicago, IL, USA. · Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 28318726
  • Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Research Data Management and Statistics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom. · Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: · Pubmed 28939224
  • 1 Cancer Research UK Cancer Imaging Centre, MRI Unit, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, UK. · 2 Academic Urology Unit, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · 3 Statistics Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 28609110
  • 1 Cancer Research UK Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 2 Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · 3 Department of Histopathology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 28055249
2016
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26691314
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • School of Social and Community Medicine, University of Bristol, Bristol, UK. · NIHR Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, UK. · Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. · Institution of Surgical Sciences, Department of Urology, Uppsala University, Uppsala, Sweden. · Department of Urology, Johns Hopkins School of Medicine, Baltimore, MA, USA. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · National Institute on Aging, National Institutes of Health, Baltimore, MA, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Faculty of Life Sciences and Medicine, King's College London, London, UK. · Regional Cancer Centre, Uppsala/Örebro Region, Uppsala, Sweden. · Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA. · Department of Oncology, University of Cambridge, Cambridge, UK. · Academic Urology Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK. · Pubmed 26799945
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. · Institute of Cancer Research, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address: · Pubmed 26482887
2015
  • CRUK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 26258905
2014
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2009
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 19549256
2007
  • Academic Urology Unit, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK. · Pubmed 17535273
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2014
  • MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK. · Pubmed 24103544
2012
  • Division of Surgery and Interventional Sciences, University College London, London, UK. · Pubmed 22077593
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. · Pubmed 20714343
2008
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom. · Pubmed 18342430
2007
  • Drug Development Unit and Department of Academic Urology, Royal Marsden Hospital, Centre for Cancer Therapeutics, Institute for Cancer Research, Surrey, United Kingdom. · Pubmed 17235043
Unspecified
2017
  • Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas, NV. Electronic address: · Weston Park Hospital, Department of Oncology, Sheffield, UK. · Washington University School of Medicine, Radiation Oncology, St Louis, MO. · Karolinska University Hospital, Department of Oncology, Stockholm, Sweden. · Queen's University, Centre for Cancer Research and Cell Biology, Belfast, UK. · Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Academic Urology Unit, Sutton, UK. · Umeå University, Department of Radiation Sciences, Umeå, Sweden. · Statisticon AB, Biostatistics Department, Uppsala, Sweden. · Bayer HealthCare Pharmaceuticals, Global Medical Affairs Oncology, Whippany, NJ. · Bayer HealthCare Pharmaceuticals, US Medical Affairs Oncology, Whippany, NJ. · Tulane Cancer Center, Departments of Medicine and Urology, New Orleans, LA. · Pubmed 27613490
  • Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK; Department of Urology, UCLH NHS Foundation Trust, London, UK. Electronic address: · Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK; Department of Urology, UCLH NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Hull York Medical School and Department of Health Sciences, University of York, UK. · Department of Urology, Hampshire Hospitals NHS Foundation Trust, UK. · Department of Histopathology, UCLH NHS Foundation Trust, London, UK. · Department of Radiology, UCLH NHS Foundation Trust, London, UK. · Public and patient representative, Nottingham, UK. · Department of Academic Urology, Royal Marsden Hospital, Sutton, UK. · Pubmed 28110982
2016
  • a Departments of Radiotherapy and Urology , The Royal Marsden Hospital , Sutton , UK. · b Department of Radiotherapy & Imaging , The Institute of Cancer Research , Sutton , UK. · Pubmed 27501059
  • Department of Oncology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK. · Cancer Research Unit, University of Warwick, Coventry, UK. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK. · Health Economics Unit, University of Birmingham, Birmingham, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Belfast City Hospital, Belfast, UK. · Department of Oncology, Royal Marsden Hospital, Sutton, UK. · Institute of Cancer and Genetics, Cardiff University, Cardiff, UK. · Velindre Cancer Centre, Cardiff, UK. · Pharmacy Department, City Hospital, Birmingham, UK. · Department of Oncology, The Christie Hospital, Manchester, UK. · Kent Oncology Centre, Maidstone Hospital, Kent, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, St James' University Hospital, Leeds, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Pubmed 27434595
  • The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: · Pubmed 26965561
  • Royal Marsden Hospital, Academic Urology Unit, Sutton, UK. Electronic address: · Pubmed 26928379
2015
  • Royal Marsden Hospital, Sutton, UK. Electronic address: · Institute of Cancer Research, Sutton, UK. · Pubmed 25442054
  • European School of Oncology, Milan, Italy; Prostate Cancer Programme, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Dept of Urology, University Hospital of the Katholieke Universiteit Leuven, Leuven, Belgium. · Renal Cancer Services, Royal Free Hospital, London, UK. · Dept of Urology, Heinrich Heine University Hospital, Düsseldorf, Germany. · Centre Polidisciplinaire d'Oncologie, Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Dept of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. · Dept of Urology, Ausl Modena, Nuovo Ospedale Civile-S. Agostino Estense, Modena, Italy. · Europa Uomo, Antwerp, Belgium; Oncological Centre, Antwerp, Belgium. · King's College Hospital NHS Foundation Trust, London, UK. · University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital-Cancer Centre, Birmingham, UK. · Europa Uomo, Antwerp, Belgium; Bundesverband Prostatakrebs Selbsthilfe, Bonn, Germany. · Greater Manchester Strategic Health Authority, Manchester, UK. · Dept. of Radiation Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Belgium. · Urologic and Radiation Oncology, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland. · Dept of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Integraal Kankercentrum Nederland (IKNL), Comprehensive Cancer Centre Netherlands, Utrecht, The Netherlands. · Dept of Oncology and Palliative Medicine, Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Dept of Urology, University of Naples Federico II, Naples, Italy. · Dept of Urology, Bonn University Hospital, Bonn, Germany. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. · Breast Cancer Unit, Institut Gustave Roussy, Villejuif, France. · Dept of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Dept of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Dept of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Research Department of Clinical, Educational and Health Psychology, University College, London, UK. · Deutsche Krebsgesellschaft, German Cancer Society, Berlin, Germany. · Dept of Radiation Oncology, University Hospital Ulm, Ulm, Germany. · Prostate Cancer Programme, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · European School of Oncology, Milan, Italy. · Pubmed 26092320
  • Ipswich Hospital NHS and University Campus Suffolk, Ipswich, UK. · Institute of Cancer Research, Sutton, UK. · Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, India. · Royal Marsden Hospital, Sutton, UK. · Royal Marsden Hospital, Sutton, UK. Electronic address: · Pubmed 25457497
2014
  • University Medical Centre, Utrecht, The Netherlands. Electronic address: · University College London, London, UK. · Erasmus University Medical Centre, Rotterdam, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · CHRU Lille, Université Lille Nord de France, Lille, France. · Royal Marsden Hospital, Sutton, UK. · Pubmed 24491309
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Academic Urology Unit, Royal Marsden Hospital, Sutton SM2 5PT, UK. Electronic address: · Pubmed 24831980
2013
  • Institute of Cancer Research and Royal Marsden Hospitals Foundation Trust, Sutton, UK. · Pubmed 23578233
  • Royal Marsden NHS Foundation Trust, Sutton, UK. · Pubmed 23953599
2013
  • Royal Marsden Hospital, Sutton, UK. · Pubmed 23316941
  • Oncogenetics team, The Institute of Cancer Research. · Pubmed 23320731
  • Strangeways Laboratory, Centre for Cancer Genetic Epidemiology, Worts Causeway, Cambridge CB1 8RN, UK. · Pubmed 23065704
2012
  • Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, UK. · Pubmed 22388664
  • Academic Urology Unit, Royal Marsden Hospital, Sutton, UK. · Pubmed 23110500
  • Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. · Pubmed 23059046
2010
  • Academic Urology Unit, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Surrey, UK. · Pubmed 20092961
  • Department of Clinical Oncology, Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK. · Pubmed 20358422
2008
2007
Miscellaneous institutions in Salamanca
2011
  • Queen’s University, Kingston, Canada (DFS, SB, CT) · Azienda ULSS 18, Rovigo, Italy (CC) · Marmara University Hospital, Istanbul, Turkey (UA) · Maria Sk1odowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland (MGS, AH) · Department of Radiation Oncology (MAASTRO Clinic), GROW—School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands (FvG, MPJ) · Istanbul Bilim University, Istanbul, Turkey (SI) · Instituto Oncolo´ gico del Valle´ s (Barcelona)–Hospital Clı´nico Universitario (Salamanca), Spain (VM, CP, NP) · University Hospital Santa Maria, Lisbon, Portugal (IMG) · Institute of Cancer Research and Royal Marsden NHS Trust, London, England (CM) · Klinik fu¨ r Strahlentherapie, Magdeburg, Germany (HW) · Pubmed 21273630
37 Other Locations Show
Yearly article counts 0121510141612912141314
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.